1192548-05-2 Usage
Uses
Used in Organic Synthesis:
3-Fluoro-2-(trifluoromethyl)benzeneboronic acid pinacol ester, 96% is used as a reagent for the preparation of various biaryl compounds in organic synthesis. Its versatility and high purity level make it a reliable and effective tool for researchers in this field.
Used in Pharmaceutical Industry:
3-Fluoro-2-(trifluoromethyl)benzeneboronic acid pinacol ester, 96% is used as a building block for the synthesis of pharmaceutical compounds. Its unique functional groups, including a fluoro and trifluoromethyl group, make it a valuable component in the development of new drugs.
Used in Chemical Research:
3-Fluoro-2-(trifluoromethyl)benzeneboronic acid pinacol ester, 96% is used as a research tool in chemical studies. Its high purity and reactivity make it an ideal candidate for investigating new reaction pathways and exploring the properties of biaryl compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1192548-05-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,2,5,4 and 8 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1192548-05:
(9*1)+(8*1)+(7*9)+(6*2)+(5*5)+(4*4)+(3*8)+(2*0)+(1*5)=162
162 % 10 = 2
So 1192548-05-2 is a valid CAS Registry Number.
1192548-05-2Relevant articles and documents
KRAS G12D INHIBITORS
-
Paragraph 01090, (2021/03/05)
The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.
AMINO ACID COMPOUNDS
-
Page/Page column 51, (2009/12/23)
[Problem] To provide novel compounds that are S1P1 receptor agonists and exhibit an immunosuppressive activities by inducing lymphocyte sequestration in secondary lymphoid tissues. In addition, to provide a pharmaceutical agent which comprises the compounds as an effective component, in particular to provide a therapeutic and/or prophylactic agent for an autoimmune disease and the like. [Solving Means] Amino acid compounds that are represented by the following Formula (1) are provided